Click to view a DBS procedure video featuring the microTargeting™ Platform

 
NEW- StimPulse    

A New Sophisticated and Affordable Stimulator for Neuroscience Research

FHC proudly introduces the feature rich neuro/craft™ StimPulse, offering neuroscientists flexibility and high performance.

• Simple or complex pulse and train programming with micro-second resolution and arbitrary waveform support in a single channel device.

• Intuitive touch screen interface displays actual or ideal output during stimulus cycles.

• Isolated output coupling and shielding options minimize noise artifacts and safely protect subjects.  

Budget capital investment wisely with this efficient solution that incorporates most electrical micro-stimulation requirements in one compact system.

To view a technical information sheet on the StimPulse, click here.

  
    The StimPulse is comprised of two devices: the PGM Pulse Generator Module and the digitally isolated ESG Electrical Stimulus Generator.  

Now Taking Orders!

 

click to view our Clinical Products Catalog
             
    For additional information contact Justin Crouse at 800-326-2905 (US & Canada), +1-207-666-8190, or jcrouse@fh-co.com.    
             
           

Introducing the Guideline 4000 LP+™

neuromodulation targeting system

 
The newest member of the Guideline 4000™ family, optimized for clinical use with high-powered research support.

click to view more information

    
   

click to view our ad in the current edition of "US Neurology"
           
                   

Advanced Microelectrode Recording System Supports High Precision Targeting of Deep Brain Structures

FHC Launches Guideline 4000™ Software Release Version 1.4

Bowdoin, ME, December 11, 2009:  

FHC, leading neuroscience product manufacturer, announces an upgrade release for its neurosurgical microelectrode recording (MER) product, the Guideline 4000™ Neuromodulation Targeting System. The Guideline 4000™ supports microelectrode recording of neural activity and brain stimulation procedures.

(To read on, click here.)

  

 

 
                   

FHC Introduces the New microTargeting™ Star™ Drive

 

 

 

On September 18th, leading neuroscience product manufacturer, FHC, received Food and Drug Administration clearance to market and sell its new microTargeting™  Star™ Drive in the United States. A CE mark awarded earlier in the month endorsed European promotion and sale. American and European FHC validation partners report a strong interest in the system for its smooth, stable and uncomplicated operation. (To read on, click here.)

Now cleared for use in Canada!
                       
“Innovation through collaboration”

FHC Inc. 1201 Main Street, Bowdoin, ME 04287
Tel: 207-666-8190, Canada & US 1-800-326-2905,
Fax: 207-666-8292, email: fhcinc@fh-co.com